Cancer Immunology Project (CIP)

[email protected]

USERN_GROUP_logo

Objective

Immunotherapeutic strategies which are applied for many types of cancer are indebted to basic and clinical research in various fields such as medicine, immunology, molecular biology, genetics, biotechnology, nanotechnology, as well as their combination in interdisciplinary studies. The Cancer Immunology Project (CIP) is a research interest group established within the Universal Scientific Education and Research Network (USERN) and aims at providing science without borders by connection of talent and interested juniors with leading scientists of the field.

Definition

Cancer as the second leading cause of death in the world is a serious threat to human life. During the centuries, different types of treatment have been investigated to benefit the patients suffering from cancer. Knowledge of the interaction between the immune system and tumor cells is being extended by performing research on cellular and molecular immunology. In order to find novel immunologic methods to fight cancer, deep understanding of the natural and pathologic processes of the immune system is required.

Group members

Founder

Managing Director

Mahsa Keshavarz-Fathi

Member

Education Deputy

Sepideh Razi

Book

Cancer Immunology: A Translational Medicine Context

NULL

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

NULL

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

NULL

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Cancer Immunology: A Translational Medicine Context, Second Edition

NULL

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition

NULL

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, Second Edition

NULL

Nowroozi A, Razi S, Sahu KK, Grizzi F, Arends J, Keshavarz-Fathi M, Rezaei N. COVID-19 in Patients with Cancer. Adv Exp Med Biol. 2021;1318:315-331.

NULL

Moossavi S, Fehr K, Maleki H,..., Popescu S, Keshavarz-Fathi M, Rezaei N. Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions. Adv Exp Med Biol. 2021;1318:575-604.

NULL

Rezaei N, Ashkevarian S, Fathi MK,..., Ziaei H, Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. Adv Exp Med Biol. 2021;1318:1-22.

NULL

Saghazadeh A., Rezaei N. (2017) Cancer Immunotherapy: Friend or Foe of Mental Health?. In: Mehdipour P. (eds) Cancer Genetics and Psychotherapy. Springer, Cham.

NULL

Khalili N. The Immunogenetics of Cutaneous Drug Reactions. Adv Exp Med Biol. 2022;1367:411-431.

Book Chapter

Darbeheshti F. The Immunogenetics of Melanoma. Adv Exp Med Biol. 2022;1367:383-396.

Book Chapter

Keshavarz-Fathi M, Keshavarz-Fathi M, Rezaei N. Cancer Immunology. In: Rezaei N, editor. Encyclopedia of Infection and Immunity. Oxford: Elsevier; 2022. p. 277-95.

Book Chapter

Behrouzieh, S. et al. (2022). Ethical Deliberation on AI-Based Medicine. In: Rezaei, N. (eds) Multidisciplinarity and Interdisciplinarity in Health. Integrated Science, vol 6. Springer, Cham.

Book Chapter

Rezaei, N. et al. (2022). Integrated Science 2050: Multidisciplinarity and Interdisciplinarity in Health. In: Rezaei, N. (eds) Multidisciplinarity and Interdisciplinarity in Health. Integrated Science, vol 6. Springer, Cham.

Book Chapter

Mahdavi Sharif P, Pastaki Khoshbin A, Nasrollahzadeh E, Keshavarz-Fathi M, Rezaei N. Chapter 4 - Tumor immunology. In: Rezaei N, editor. Clinical Immunology: Academic Press; 2023. p. 245-452.

NULL

Pezeshki Ps, Nowroozi A, Razi S, Rezaei N. Chapter 2 - Asthma and Allergy. In: Rezaei N, editor. Clinical Immunology. Academic Press; 2023. p. 47-122.

NULL

Saleki K, Razi S, Rezaei N. Chapter 6 - Infection and Immunity. In: Rezaei N, editor. Clinical Immunology. Academic Press; 2023. p. 493-598.

NULL

Farshbafnadi M, Razi S, Rezaei N. Chapter 7 - Transplantation. In: Rezaei N, editor. Clinical Immunology. Academic Press; 2023. p. 599-674.

NULL

Soleymanitabar A, Keshavarz-Fathi M, Hargadon KM, Rezaei N. Immunotherapy for Cutaneous Melanoma. In: Rezaei N, editor. Handbook of Cancer and Immunology. Cham: Springer International Publishing; 2022. p. 1-35.

NULL

Zonouzi, S.K., Razi, S., Rezaei, N. (2023). Introduction to Cancer Treatment. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Ghaedi E, Esfahani SA, Keshavarz-Fathi M, Rezaei N. Molecular Mechanisms of Metal-Induced Carcinogenesis. Cham: Springer International Publishing. p. 1-66.

NULL

Mousavi, A., Gharibpoor, F., Razi, S., Rezaei, N. (2023). Immunotherapy in Gastrointestinal Cancer Focusing on CAR-T Cell Therapy. In: Interdisciplinary Cancer Research. Springer, Cham.

NULL

Razi, S., Rezaei, N. (2023). Introduction on Cancer Immunotherapy. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Shafeghat, M., Balibegloo, M., Rezaei, N. (2023). Interdisciplinary Approach in Genitourinary Cancers. In: Interdisciplinary Cancer Research. Springer, Cham.

NULL

Danandeh, K., Balibegloo, M., Rezaei, N. (2023). Interdisciplinary Approach in Gastrointestinal Cancers. In: Interdisciplinary Cancer Research. Springer, Cham.

NULL

Pezeshki, P.S., Rezaei, N. (2023). Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Farshbafnadi, M., Rezaei, N. (2023). The Metabolism of Cancer Cells During Metastasis. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Cancer Research: An Interdisciplinary Approach

NULL

Saghazadeh, A., Rezaei, N. (2023). Myeloid-Derived Suppressor Cells and Cancer Metastasis. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_68-1

NULL

Mohammadi-Motlagh, HR., Sadeghalvad, M., Rezaei, N. (2023). Introduction on Cancerous Cells and Metastasis. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Pour-Rashidi, A., Yazdanpanah, N., Rezaei, N. (2023). Introduction on Cancer Modifiable Risk Factors and Prevention. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham

NULL

Sadeghalvad, M., Mohammadi-Motlagh, HR., Rezaei, N. (2023). Introduction to Cancer Immunology. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Rahavi-Ezabadi, S., Rezaei, N. (2023). Immunotherapy for Nasopharyngeal Cancer. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Maroufi, S.F., Mohammadi, E., Namvar, M., Iranmehr, A., Rezaei, N., Hanaei, S. (2023). Immunotherapy for Primary Cancers of Central Nervous System. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Khalili, N., Rezaei, N. (2023). Imaging of Tumor-Associated Macrophages. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Sharifi, L., Rezaei, N. (2023). Immune Checkpoint Inhibitors in Urological Cancers. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Seyedmirzaei, H., Rezaei, N. (2023). Epigenetics and Circular RNAs in Cancer. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Nejadghaderi, S.A., Rezaei, N. (2023). Health Crisis and Cancer Prevention: Friend or Foe. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Mohebalizadeh, M., Rezaei, N. (2023). Biomarkers for Monitoring the Immunotherapy Response to Cancer. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Farhat, S., Rezaei, N. (2023). Tumor Hyperprogression and Pseudoprogression After Immunotherapy. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Moradian, N., Rezaei, N. (2023). The Role of Autophagy Regulation as a Novel Approach for Cancer Immunotherapy. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Bahreini, F., Rezaei, N. (2023). The Role of MicroRNAs in Chemoresistance. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Khalili, N., Rezaei, N. (2023). The Utility of Radiomics in Predicting Response to Cancer Immunotherapy. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Soltani Khaboushan, A., Neishabouri, A., Rezaei, N. (2023). Tissue Engineering and Regenerative Medicine in Cancer Therapy. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Khanmohammadi, S., Rezaei, N. (2023). Tumor Associated Neutrophils (TANs) and Cancer Metastasis. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Arabpour, M., Rezaei, N. (2023). The Role of Non-coding RNAs in Drug Resistance of Cancers. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Nasrollahzadeh, E., Rezaei, N. (2023). Time to Sleep: Immunologic Niche Switches Tumor Dormancy at Metastatic Sites. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Kolahchi, Z., Rezaei, N. (2023). Role of T Helper 17 in Cancer Pathology: A Double-Edge Sword. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Saghazadeh, A., Rezaei, N. (2023). Artificial Intelligence: A Tool to Help Cancer Diagnosis, Prognosis, and Treatment. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Mohammadi, E., Maroufi, S.F., Rezaei, N., Hanaei, S. (2023). Cancer Prognosis in Brief. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Yazdanpanah, F., Rezaei, N. (2023). An Immune-Related Gene Signature for Determining Tumor Prognosis Based on Machine Learning. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham.

NULL

Ajjh

Hbvdfhj

Paper

Hoseinpour P, Olfatbakhsh A, Keshavarz-Fathi M, Beheshtian T, Hashemi E A, Hoseinpour P. Dermatofibrosarcoma Protuberans; Case Report of a Rare Tumor of the Breast. MCI. 2017; 1 (1) :26-28 URL: http://mcijournal.com/article-1-50-en.html

2. Mahsa Eskian, MirHojjat Khorasanizadeh, Francoise Kraeber-Bodere, Nima Rezaei, Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response, Critical Reviews in Oncology/Hematology, Volume 107, November 2016, Pages 182-189, IS...

Saeed Soleyman-Jahi, Afshin Abdirad, Amir Afraz Fallah, Sevil Ghasemi, Fatemeh Sadeghi, Reza Heidari, Habibollah Mahmoodzadeh, Kazem Zendehdel. Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: thre...

Dehghan Manshadi, S. A., Rezahosseini, O., Saberi, S., Salahshour, F. and Mahdavi Izadi, S. (2017), Collapsed membranes within pelvic cyst: What is the diagnosis?. Clin Case Rep. doi:10.1002/ccr3.767

NULL

Jalaeikhoo H, Rajaeinejad M, Keyhani M, Keshavarz-Fathi M. A Case Report of a Metastatic Primary Gastric Lymphoma; Diffuse Large B-Cell or Burkitt Lymphoma?. MCI. 2017; 1 (2) :32-35

NULL

Yousefi H, Yuan J, Keshavarz-Fathi M, Murphy JF, Rezaei N. Immunotherapy of cancers comes of age. Expert Review of Clinical Immunology. 2017:1-15.

Fulltext http://www.tandfonline.com/eprint/nPGTxjyqswD4BsQSFKAd/full

Rezahosseini O, Hanaei S, Hamadani M, Keshavarz-Fathi M and Rezaei N (2017). "The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma." International Reviews of Immunology: 1-9.

NULL

Khajeh Alizadeh Attar M, Anwar MA, Eskian M, Keshavarz-Fathi M, Choi S, Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis. Med Res Rev. 2017 Dec 28. doi: 10.1002/med.21...

Fulltext: http://onlinelibrary.wiley.com/doi/10.1002/med.21480/pdf

Farajzadeh Valilou S, Keshavarz-Fathi S, Silvestris N, Argentiero A, Rezaei N, The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer, Cytokine & Growth Factor Reviews, Available online 12...

NULL

Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N. Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology / Hematology. 2018;127:91-104, https://10.1016/j.critrevonc.2018.05.006

NULL

Khalili N, Keshavarz-Fathi M, Shahkarami S, Hirbod-Mobarakeh A, Rezaei N. Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review. Journal of Oncology Pharmacy Practice. 2018

NULL

Pastaki Khoshbin, A., Eskian, M., Keshavarz-Fathi, M. Rezaei, N. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond. Arch. Immunol. Ther. Exp. (2018). https://doi.org/10.1007/s00005-018-0531-9

NULL

Afshari F, Soleyman-Jahi S, Keshavarz-Fathi M, Roviello G, Rezaei N. The promising role of monoclonal antibodies for gastric cancer treatment. Immunotherapy. 2019;11(4):347-64.

NULL

Razi S, Baradaran Noveiry B, Keshavarz-Fathi M, Rezaei N. IL-17 and colorectal cancer: From carcinogenesis to treatment. Cytokine. 2019;116:7-12.

Fulltext available via: https://authors.elsevier.com/a/1YRzo3jGS1BQZy

Rezaei N, Rayzan E. Cancer Immunotherapy: The way to the Nobel Prize in Medicine. Acta Med Iran. 56(10):623-624.

NULL

Eskian M, Khorasanizadeh M, Zinzani PL, Illidge TM & Rezaei N. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma, International Reviews of Immunology, 2019; 38:2, 79-91

NULL

Mahmoudi M, Taghavi-Farahabadi M, Rezaei N, Hashemi SM, Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis, International immunopharmacology, Jun 2019, 10...

NULL

Ghaemdoust F, Keshavarz-Fathi M, Rezaei N. Natural killer cells and cancer therapy, what we know and where we are going. Immunotherapy. 2019.

NULL

Mahmoudi M, Taghavi-Farahabadi M, Rezaei N, Hashemi SM. Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis. International immunopharmacology. 2019;74:10568...

NULL

Soleyman-Jahi S, Sadeghi F, Pastaki Khoshbin A, Khani L, Roosta V, Zendehdel K. Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy. Frontiers in Oncology. 2019;9(1014).

NULL

Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert review of clinical immunology. 2020: 10.1080/1744666X.2020.1713755

Fulltext: https://www.tandfonline.com/eprint/QUVHYBJT2HAHVNEZS2SI/full?target=10.1080/1744666X.2020.1713755

Ebrahimi M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. Effects of lead and cadmium on the immune system and cancer progression. Journal of Environmental Health Science and Engineering. 2020: 10.1007/s40201-020-00455-2.

NULL

Mahdavi Sharif P, Jabbari P, Razi S, Keshavarz-Fathi M, Rezaei N. Importance of TNF-alpha and its alterations in the development of cancers. Cytokine. 2020;130:155066.

Fulltext: https://authors.elsevier.com/a/1amiE_NkSPkKi2

Aghamiri S, talaei S, Roshanzamiri S, Zandsalimi F, Fazeli E, Aliyu M, et al. Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy. Expert Opinion on Drug Delivery. 2020:1-14.

NULL

Keshavarz-Fathi M, Sanati G, Sadr M, Mohebbi B, Ziaei V, Rezaei N. DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus. Fetal and Pediatric Pathology. 2020:1-10

NULL

Nasrollahzadeh E, Razi S, Keshavarz-Fathi M, Mazzone M, Rezaei N. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. Cancer Immunology, Immunotherapy. 2020

NULL

Balibegloo M, Rezaei N. Development and Clinical Application of Bispecific Antibody in the Treatment of Colorectal Cancer. Expert Review of Clinical Immunology. 2020.

NULL

Zargarbashi R, Panjavi B, Keshavarz-Fathi M. Extensive Deep Tissue Involvement in Nicolau Syndrome and Below-Knee Amputation: A Case Report and Literature Review. Int J Low Extrem Wounds. 2020

NULL

Pezeshki S, Hemmati S, Rezaei N. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma. Expert Review of Anticancer Therapy. 2020

NULL

Shahnaz A, Keyvan R, Bibi Shahin S, Zahra C, Maryam E, Alireza Zare B et al. Novel CD40LG Mutation in Two Cousins With Immunoglobulin Class Switch Recombinant Deficiency. Acta Medica Iranica. 2020;57(11)

NULL

Najdaghi S, Razi S, Rezaei N. An overview of the role of interleukin-8 in colorectal cancer. Cytokine. 2020;135:155205

NULL

Rezalotfi A, Vrynas AV, Dehghanian M, Rezaei N. Lessons from the Embryo: an Unrejected Transplant and a Benign Tumor. Stem Cell Reviews and Reports. 2020

NULL

Abrishami A, Eslami V, Baharvand Z, Khalili N, Saghamanesh S, Zarei E et al. Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship? International immunopharmacology. 2020:107174

NULL

Khalili N, Nouri-Vaskeh M, Hasanpour Segherlou Z, Baghbanzadeh A, Halimi M, Rezaee H, Baradaran B. Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers. Life Sci. 2020 Sep 1;256:117865

NULL

Momtazmanesh S, Rahmani F, Delavari F, Vahedi Z, Ebadirad S, Keshavarz-Fathi M, et. al., U100: An Innovative USERN Platform for Education and Research Without Borders. Acta Med Iran. 58(1):1-3.

NULL

Rayzan E, Farajzadeh Valilou S, Sadeghi MA, Hemmati S, et al. HMGB1 polymorphisms in acute lymphoblastic leukemia. Authorea. November 11, 2020.

Khalili N, Mohammadzadeh I, Khalili N, Heredia RJ, Zoghi S, Boztug K et al. BCGitis as the primary manifestation of chronic granulomatous disease. IDCases. 2021;23:e01038

NULL

Abrishami A, Khalili N, Kooraki S, Abrishami Y, Grenacher L, Kauczor H-U. Evaluation of cross-sectional imaging features that aid in the differentiation of benign and malignant splenic lesions. European Journal of Radiology. 2021;136

NULL

Razavi A, Keshavarz-Fathi M, Pawelek J, Rezaei N. Chimeric Antigen Receptor T-cell Therapy for Melanoma, Expert Review of Clinical Immunology. 2021.

NULL

Seyedmirzaei H, Keshavarz-Fathi M, Razi S, Gity M, Rezaei N. Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2). Journal of Oncology Pharmacy Practice. 2021.

NULL

Razavi A, Hamblin MR, Rezaei N. COVID-19 in patients with cancer: Risks and precautions. Am J Emerg Med. 2021

NULL

Hanaei S, Sarzaeim M, YazdanpanahN, Rahimi Pirkoohi Z, Ziaei H, Mohamed K, Samieefar N, Keshavarz-Fathi M, Kolahchi Z, Moradian N, MomtazmaneSh S, Seyedpour S, Jaberipour A, Ashkevarian S, Rezaei N. The Hybrid USERN 2020 Congress: New Standards for E...

NULL

Makuku R, Khalili N, Razi S, Keshavarz-Fathi M, Rezaei N. Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy. Journal of Immunology Research. 2021;2021:6661406.

NULL

Keshavarz-Fathi M, Rezaei N. Cancer Immunoprevention: Current Status and Future Directions. Archivum immunologiae et therapiae experimentalis. 2021;69(1):3

NULL

Jalalvand M, Darbeheshti F, Rezaei N. Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer. Immunotherapy. 2021 Mar 29.

NULL

Pezeshki PS, Eskian M, Hamblin MR, Rezaei N. Immune checkpoint inhibition in classical hodgkin lymphoma. Expert Rev Anticancer Ther. 2021

NULL

Sedighzadeh SS, Khoshbin AP, Razi S, Keshavarz-Fathi M, Rezaei N. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications. Translational Lung Cancer Research. 2021;10(4):18...

NULL

Pezeshki PS, Mahdavi Sharif P, Rezaei N. Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 inhibitors. Expert Opin Biol Ther. 2021.

NULL

Pirzadeh M, Khalili N, Rezaei N. The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer. Int Rev Immunol. 2020 Nov 25:1-42

NULL

Balibegloo M, Nejadghaderi SA, Sadeghalvad M, Soleymanitabar A, Salehi Nezamabadi S, Saghazadeh A et al. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis. International...

NULL

Zargarbashi R, Bagherpour A, Keshavarz-Fathi M, Panjavi B, Bagherpour Zarchi M. Prognosis of Congenital Pseudarthrosis of the Tibia: Effect of Site of Tibial Pseudarthrososis and Fibular Involvement. Journal of Pediatric Orthopaedics. 2021

NULL

Abrishami A, Alborzi Avanaki M, Khalili N, Taher M, Ghanaati H. Multi-organ infarction following percutaneous transhepatic esophageal variceal obliteration with glue injection: a case report. Radiol Case Rep. 2021 May 13;16(7):1828-1832

NULL

Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. Immune microenvironment in different molecular subtypes of ductal breast carcinoma. Breast Cancer Res Treat. 2021 Jan;185(2):261-279.

NULL

Taghavi-Farahabadi M, Mahmoudi M, Mahdaviani SA, Baghaei K, Rayzan E, Hashemi SM, Rezaei N. Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells' exosomes. Hum Immunol. 2020 Oct-Nov;81(10-11):...

NULL

Poorebrahim M, Mohammadkhani N, Mahmoudi R, Gholizadeh M, Fakhr E, Cid-Arregui A. TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer Gene Ther. 2021 Mar 2. doi: 10.1038/s41417-021-00307-7. Epub ahead of print. Erratum in:...

NULL

Mohtashami M, Razavi A, Abolhassani H, Aghamohammadi A, Yazdani R. Primary Immunodeficiency and Thrombocytopenia. Int Rev Immunol. 2021 Jan 19:1-43.

NULL

Armin S, Ramezani K, Shamsian BS, Chavoshzadeh Z, Eghbali M, Zare Bidoki A, Sadr M, Mesdaghi M, Gorjipour H, Razi S, Rezaei N. Novel CD40LG Mutation in Two Cousins With Immunoglobulin Class Switch Recombinant Deficiency. Acta Med Iran. 57(11):678-681...

NULL

Mahmoudi M, Taghavi-Farahabadi M, Namaki S, Baghaei K, Rayzan E, Rezaei N, Hashemi SM. Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro. Hum Immunol. 2019...

NULL

Seyedizade SS, Afshari K, Bayat S, Rahmani F, Momtaz S, Rezaei N, Abdolghaffari AH. Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease. Arch Immunol Ther Exp (Warsz). 2020 Apr 1;68(2):10.

NULL

Hanaei S, Afshari K, Hirbod-Mobarakeh A, Mohajer B, Amir Dastmalchi D, Rezaei N. Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis. Rev Neurosci. 2018 Jun 27;29(4):443-461.

NULL

Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, Barbouche MR, McKinlay MA, Aghamohammadi A. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5...

NULL

Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers. Immunol Invest. 2016 Oct;45(7):619-40.

NULL

Shaghaghi M, Irannejad M, Abolhassani H, Shahmahmoodi S, Hamidieh AA, Soleyman-Jahi S, Yazdani R, Azizi G, Aghamohammadi A. Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of L...

NULL

Sadeghi F, Shirkhoda M. Allergy-Related Diseases and Risk of Breast Cancer: The Role of Skewed Immune System on This Association. Allergy Rhinol (Providence).

NULL

Farshbafnadi M, Pastaki Khoshbin A, Rezaei N. Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence. International Immunopharmacology, 2021.

NULL

Moeinafshar A, Hemmati S, Rezaei N. Immunotherapy in AML: a brief review on emerging strategies. Clin Transl Oncol. 2021 Jun 23.

NULL

Shaafi S, Hadisi F, Mahmoudinezhad M, Razmi H, Nejadghaderi SA, Khalili M. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study. BMC Neurol. 2021 Jul 2;21(1):258.

NULL

Pezeshki PS, Moeinafshar A, Ghaemdoust F, Razi S, Keshavarz-Fathi M, Rezaei N. Advances in Pharmacotherapy for Neuroblastoma. Expert Opinion on Pharmacotherapy. 2021.

NULL

Abrishami A, Ziaeefar P, Ebrahimi S, Khalili N, Nouralizadeh A, Farjad R. Rosai-Dorfman disease: A case report of asymptomatic isolated renal involvement. Clin Case Rep. 2021 Jul 10;9(7):e04132.

NULL

Fallah M, Davoodvandi A, Nikmanzar S, Aghili S, Mirazimi SMA, Aschner M, Rashidian A, Hamblin MR, Chamanara M, Naghsh N, Mirzaei H. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomed Pharmacother. 2021 Aug 13;1...

NULL

Davoodvandi A, Marzban H, Goleij P, Sahebkar A, Morshedi K, Rezaei S, Mahjoubin-Tehran M, Tarrahimofrad H, Hamblin MR, Mirzaei H. Effects of therapeutic probiotics on modulation of microRNAs. Cell Commun Signal. 2021 Jan 11;19(1):4.

NULL

Abrishami A, Zadeh A, Khalili N, Yazdi H (2021). Balloon-occluded antegrade transvenous obliteration of rectal varices: A case report. Radiology Case Reports. 16. 3363-3368.

NULL

Ghaffari, S., Khalili, N. & Rezaei, N. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy. J Exp Clin Cancer Res 40, 269 (2021).

NULL

Tobeiha M, Rajabi A, Raisi A, Mohajeri M, Yazdi SM, Davoodvandi A, et al. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. Biomed Pharmacother. 2021 Oct 20

NULL

Behrouzieh S, Sheida F, Rezaei N. Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy. Expert Rev Anticancer Ther. 2021 Nov 8:1-16.

NULL

Razavi AS, Mohtashami M, Razi S, Rezaei N. TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends? Cytokine. 2021 Nov 20;150:155772

NULL

Sheida F, Razi S, Keshavarz-Fathi M, Rezaei N. The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies. Expert Rev Anticancer Ther. 2021 Nov 25.

NULL

Keshavarz-Fathi M, Sanati G, Sadr M, Mohebbi B, Ziaee V, Rezaei N. Aberrant DNA methylation of the promoters of JAK2 and SOCS3 in juvenile systemic lupus erythematosus. European Cytokine Network. 2021;32(3):48-54

NULL

Kamali Zonouzi, S., Pezeshki, P.S., Razi, S. et al. Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol (2021).

NULL

Sadeghian, D., Saffar, H., Mahdavi Sharif, P. et al. MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers. Diagn Pathol 17, 24 (2022).

NULL

Makuku R, Seyedmirzaei H, Tantuoyir MM, Rodríguez-Román E, Albahash A, Mohamed K, Moyo E, Ahmed AO, Razi S, Rezaei N. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article. Internatio...

NULL

Nouri-Vaskeh M, Khalili N, Sadighi A, Yazdani Y, Zand R. Biomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons. J Clin Med. 2022 Feb 17;11(4):1046.

NULL

Moeinafshar, A., S. Razi, and N. Rezaei, Interleukin 17, the double-edged sword in atherosclerosis. Immunobiology, 2022. 227(3): p. 152220.

NULL

Ali Nowroozi, Nastaran Khalili, Sepideh Razi, Mahsa Keshavarz-Fathi & Nima Rezaei (2022) Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms, Expert Opinion on Biological Therapy

NULL

Zokaei E, Darbeheshti F, Rezaei N. Prospect of exosomal circular RNAs in breast Cancer: presents and future. Mol Biol Rep. 2022 May 9.

NULL

Darbeheshti F, Kadkhoda S, Keshavarz-Fathi M, Razi S, Bahramy A, Mansoori Y, et al. Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness. BMC Cancer. 2022;22(1):66...

NULL

Gharibpoor, F., Kamali Zonouzi, S., Razi, S., Rezaei, N. AMPK’s double-faced role in advanced stages of prostate cancer. Clin Transl Oncol (2022).

NULL

Davoodvandi, A., Nikfar, B., Reiter, R.J. et al. Melatonin and cancer suppression: insights into its effects on DNA methylation. Cell Mol Biol Lett 27, 73 (2022).

NULL

Zinatizadeh MR, Zarandi PK, Keshavarz-Fathi M, Yousefi MH, Rezaei N. The role of ral signaling and post translational modifications (PTMs) of Ras in cancer. Genome Instability & Disease. 2022;3(1):22-32

NULL

Mirzapour, M.H., Heidari-Foroozan, M., Razi, S. et al. The pro-tumorigenic responses in metastatic niches: an immunological perspective. Clin Transl Oncol (2022).

NULL

Ghafelehbashi, R., Farshbafnadi, M., Aghdam, N.S. et al. Nanoimmunoengineering strategies in cancer diagnosis and therapy. Clin Transl Oncol (2022).

NULL

Naghmeh Kian, Sadra Behrouzieh, Sepideh Razi & Nima Rezaei (2022) Diet Influences Immunotherapy Outcomes in Cancer Patients: A Literature Review, Nutrition and Cancer.

NULL

Zafari R, Razi S, Rezaei N. The role of dendritic cells in neuroblastoma: Implications for immunotherapy. Immunobiology. 2022;227(6):152293

NULL

Keshavarzi, E., Noveiry, B.B. & Rezaei, N. The relationship between GAD65 autoantibody and the risk of T1DM onset. J Diabetes Metab Disord 21, 1935–1942 (2022).

NULL

Samami E, Aleebrahim-Dehkordi E, Mohebalizadeh M, Yaribash S, Saghazadeh A, Rezaei N. Inosine, gut microbiota, and cancer immunometabolism. American Journal of Physiology-Endocrinology and Metabolism. 2022;324(1):E1-E8.

NULL

Sharifinejad N, Azizi G, Chavoshzadeh Z, Mahdaviani SA, Alan MS, Tavakol M et al. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features. Frontiers in Immunology. 2022;13.

NULL

Razavi AS, Loskog A, Razi S, Rezaei N. The signaling and the metabolic differences of various CAR T cell designs. International immunopharmacology. 2023;114:109593.

NULL

Asemi R, Rajabpoor Nikoo N, Asemi Z, Shafabakhsh R, Hajijafari M, Sharifi M et al. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review. Pathology - Research and Practice. 2023;246:15...

NULL

Nejadghaderi SA, Razi S, Keshavarz-Fathi M, Rezaei N. Immune Checkpoint Inhibition for Pancreatic Cancer. Acta Medica Iranica. 2023;61(3).

NULL

Hemmati S, Baradaran Noveiry B, Keshavarz-Fathi M. Cancer and Allergy; Molecular Association and Integrated Therapies. Immunology and Genetics Journal. 2023;4(4).

NULL

Pournabee M, Keshavarz-Fathi M, Esmaeili P, Mahdavi Sharif P, Nili F, Jahanbin B. Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associate...

NULL

Spoor J, Farajifard H, Keshavarz-Fathi M, Rezaei N. Historical Cohort of Severe Congenital Neutropenia in Iran: Clinical Course, Laboratory Evaluation, Treatment, and Survival. Journal of Pediatric Hematology/Oncology. 2023:10.1097/MPH.00000000000026...

NULL

Makuku R, Sinaei Far Z, Khalili N, Moyo A, Razi S, Keshavarz-Fathi M, et al. The Role of Ketogenic Diet in the Treatment of Neuroblastoma. Integrative Cancer Therapies. 2023

NULL

Manzari Tavakoli G, Mirzapour MH, Razi S, Rezaei N. Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment. International Immunopharmacology. 2023;119:110215.

NULL

Yazdanpanah N, Ziaei H, Loghman A, Lotfabadi AS, Akbarzadehmoallemkolaei M, Zolfaghari K, et al. USERNversity: A New Educational Innovation to Improve Young Scholars’ Skills via Extracurricular Programs. Acta Medica Iranica. 2023.

NULL

Keshavarz-Fathi M, Yazdanpanah N, Kolahchi S, Ziaei H, Darmstadt GL, Dorigo T, et al. Universal research index: An inclusive metric to quantify scientific research output. The Journal of Academic Librarianship. 2023;49(3):102714.

NULL

Nejadghaderi SA, Balibegloo M, Noori M, Fayyaz F, Saghazadeh A, Rezaei N. Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis. Expert Review of Anticancer Therapy. 2023;23(3):...

NULL

Gathering

Advisor and Junior Applicants Meeting

Introduction meeting of Cancer Immunology Projects for junior members, May 10th, 2016

Strategic Planning

In the meeting held on December 10th, 2016, founder and supportive advisor of CIP, Dr Nima Rezaei, the managing director and first-round members of CIP discussed about future research plan and draw their individualized line to achieve the shared goals.

Advisor and Junior Applicants Meeting 2

CIP aiming to recruit new members for the second round held an introduction meeting for new junior applicants on Jan 15th, 2017.

Collaboration with Cancer Institute, Imam Khomeini Hospital

On Nov 24th, 2020, an official meeting was held to discuss the collaboration opportunities with Cancer Institute, Imam Khomeini Hospital.

Cancer Institute Tour

Collaboration with Cancer Institute, Imam Khomeini Hospital.

Original Cancer Research 1

Jan 24th, 2021

Original Cancer Research 2

April 11th, 2021

Virtual Event

How to Write a Literature Review

NULL

Online Advances in Cancer Immunotherapy™ Courses

NULL

2021 Virtual Immuno-Oncology Symposium

Free Registration at https://www.schulich.uwo.ca/ctcr/research/Immuno-Oncology%20Symposium/io_registration.html

Congress

The First Universal Scientific Education and Research Network (USERN) Congress

Poster Presentation at the first USERN Congress, November 8th-10th, 2016

Statins and Cancer: Is It A Possible New Combination Therapy Strategy?

NULL

Macrophage-Cancer Cell Fusion and Hybridization: The Driving Force in Solid Tumor Metastasis

NULL

Spatial Profiling of The Tumor Microenvironment to Identify Biomarkers of Therapy Response

NULL

Small Molecule Immune Potentiators Targeting TLRs for the Development of Novel Chemoimmunotherapy and Vaccine Adjuvants

NULL

Promoter Methylation of JAK2 in Juvenile Systemic Lupus Erythematosus

Poster Presentation

International Cancer Webinar: Bench to Bedside

Jan 21st-23rd, 2021

A

Sf

Workshop

Virtual Workshop on Scientific Writing

Aug 22nd, 2020

Winter Research Week

Feb 27th-March 4th, 2021

Df

Fg

Oral/Poster presentation

Expression profile of three circRNAs in breast cancer

CGC2023